Collett, L., Howard, D. R., Munir, T., McParland, L., Oughton, J. B., Rawstron, A. C., . . . Hillmen, P. (2017). Assessment of ibrutinib plus rituximab in front-line CLL (FLAIR trial): Study protocol for a phase III randomised controlled trial. Trials.
Stile di citazione ChicagoCollett, Laura, et al. "Assessment of Ibrutinib Plus Rituximab in Front-line CLL (FLAIR Trial): Study Protocol for a Phase III Randomised Controlled Trial." Trials 2017.
Citazione MLACollett, Laura, et al. "Assessment of Ibrutinib Plus Rituximab in Front-line CLL (FLAIR Trial): Study Protocol for a Phase III Randomised Controlled Trial." Trials 2017.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.